Toujeo
EU-CT number 2022-500449-26-00
Approved small_molecule completed
Quick answer
Toujeo for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at MIRA PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MIRA PHARMACEUTICALS, INC.
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed